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NC-ND license (http://creativecommoAbstract Background: Laparoscopic adrenalectomy (LA) is a safe and minimally invasive
operation for benign adrenal tumours. The purpose of this study was a retrospective analysis
of outcomes following laparoscopic lateral transabdominal adrenalectomy performed for
benign adrenal tumours responsible for various endocrinological disorders and non-functioning
tumours.
Methods: A total of 100 laparoscopic adrenalectomy were carried out between January 2007
and March 2013 via the lateral transabdominal approach. The analysed factors included demo-
graphic data of patients, indication for surgery, tumour size and side, intraoperative and post-
operative outcome of laparoscopic lateral transabdominal adrenalectomy including duration of
surgery, length of hospital stay, the complication rate, as well as the conversion rate to open
adrenalectomy.
Results: There were 34 patients with non-functioning tumours (Group 1) and 66 with func-
tioning tumours (Group 2). The intraoperative and postoperative outcomes were not signifi-
cantly different in the cases among the analysed groups of patients. The median operative
time was 101  4.3 (range, 30e210) minute in group 1 and 95  5.9 (range, 30e190) minute
in group 2, there was not statistically significant (pZ 0.56). The median duration of the post-
operative hospital stay in the group 1 was bigger than group 2, this did not differ significantly
(p Z 0.08). Peroperative complications were occured in 9 (9%) patients, observing 6 (9%) pa-
tients in Group 1 and 3 (8.8%) patients in Group 2. There was not statistically significant
(p Z 0.96). In the postoperative period, three patients in group I, 1 patient in group IIf interest was declared by the authors.
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138 B. O¨z et al.developed complications, this difference was not statistically significant (p Z 0.69). The con-
version to open surgery was found in 9 (9%) patients.
Conclusion: This study shows that laparoscopic lateral transabdominal adrenalectomy is a
safe, effective, and technically feasible procedure in the treatment of both functioning and
nonfunctioning benign tumours of the adrenal gland.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Since its first description in 1992, laparoscopic adrenalec-
tomy (LA) has become a standard technique for the removal
of the adrenal gland in many centers.1,2 However,
morbidity following adrenalectomy (either via a large flank
or an abdominal incision) is high, especially in obese
patients.1e4 Many studies have demonstrated the advan-
tages of LA over open adrenalectomy, including a shorter
hospital stay, less postoperative pain, early return to daily
activities, superior cosmetic results, and reduced
morbidity.3,4 However, there is no evidence on whether
hormonal activity relative to adrenal tumor has an effect on
the results of LA.
The currently available laparoscopic approaches for
adrenalectomy are the following: lateral transabdominal,
anterior transabdominal, and posterior retroperitoneal
approaches. Each one of these has its own advantages and
disadvantages.5 While the transabdominal approach is a
suitable option for bilateral adrenal tumors and lesions >
6 cm in diameter, the retroperitoneal approach is recom-
mended for small functional and nonfunctional adrenal
adenomas.6,7 In general, nonfunctional tumors > 4 cm in
diameter is the indication for surgery, whereas functional
tumors are removed regardless of the size.8,9
The objective of this study was to present the results of
our series of patients who underwent LA with the lateral
transabdominal approach and to establish whether LA for
benign, functional, or nonfunctional adrenal tumors is a
safe and feasible technique at our institution. The results of
this study are also compared with those in the literature.
First, we compared the safety and efficacy of this proce-
dure between functional and nonfunctional tumors. Sec-
ond, we separately evaluated the results of functional
tumors and compared the results among them.2. Methods
A retrospective analysis was conducted in the Department
of General Surgery of Erciyes University Medical Faculty
Hospital, Kayseri, Turkey between January 2007 and March
2013. The Institutional Review Board of the hospital
approved the study protocol. A total of 100 patients
received LA through the lateral transperitoneal approach
by a single experienced laparoscopic endocrine surgeon.
Data were collected from patients’ medical records. Data
obtained from the patients were retrospectively analyzed.Patients were divided into two groups (Groups 1 and 2).
Group 1 consisted of 66 patients who underwent surgery for
functional adrenal tumor, and Group 2 consisted of 34 pa-
tients who underwent surgery for nonfunctional adrenal
tumor. During endocrine evaluation, if an adrenal adenoma
produces hormones, it was defined as a functional tumor, if
not as a nonfunctional tumor. Endocrine evaluation of all
patients was performed and the decision to perform the
surgery was made in consultation with the patients. With
regard to nonfunctional adrenal masses, the most impor-
tant indication for surgery was lesion size > 4 cm. We
excluded 10 patients with bilateral adrenal tumors, three
with malignant primary tumor, and one with tumor metas-
tasis, all of whom underwent LA for adrenal tumors, from
the study analysis. All included patients were evaluated in
terms of the indication for surgery, age, body mass index
(BMI, kg/m2) tumor location and size, operative time (from
the 1st incision to application of wound dressing), duration
of hospital stay, rate of conversion, blood transfusion, pre-
and postoperative complications, and conversion from
laparoscopic to open surgery.
2.1. Preoperative preparation and indications for
the operations
All patients were assessed by history and physical exami-
nations. Serum cortisol levels were measured in all pa-
tients. A 24-hour urinary free cortisol level was measured.
If the 24-hour urinary free cortisol level was higher than
that of the reference value, and the patient lacked any
specific symptoms of Cushing’s syndrome, the patient was
diagnosed as a case of “subclinical Cushing’s syndrome.”
Twenty-four-hour urinary metanephrines, normetanephr-
ines, and vanillylmandelic acid levels were evaluated in
suspected pheochromocytoma (PH) cases. Hemogram,
coagulation profile, and biochemical parameters, including
serum electrolytes, were analyzed in all cases. Adrenal
masses were localized by computed tomography or mag-
netic resonance imaging. Complete hormonal tests were
performed before the surgery in patients with incidentally
detected adrenal masses. Thyroid and neck ultrasound re-
sults and serum calcium and calcitonin levels were obtained
and reviewed for patients with PH to rule out multiple
endocrine neoplasia. If PH was diagnosed, 131I-meta-
iodobenzylguanidine scintigraphy was performed to detect
contralateral or extra-adrenal lesions.
Patients with PH received prazosin and other antihy-
pertensives 2 weeks prior to the surgery (preoperative
administration). We routinely hydrated patients
Figure 1 Right-side approach.
Figure 2 Left-side approach.
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of PH. In Conn’s disease patients with low serum levels of
potassium, a preoperative therapy with potassium and
spironolactone was indicated. The biochemical evidence
was defined by an elevated serum aldosterone-to-renin
ratio (> 20). Postoperatively, these patients were not
routinely admitted to the intensive care unit.
2.2. Management of patients during the
perioperative period
All procedures were performed under general anesthesia
through a lateral transperitoneal approach. Anesthesia was
maintained with inhalation of sevoflurane (1%) and oxygen
(50%), supplemented with remifentanil infusion. Muscle
relaxation during the operation was maintained with
rocuronium, in accordance with a neuromuscular moni-
toring guideline. Invasive arterial pressure monitoring was
routinely used for PH cases. Intraoperative hypertension
was managed with a combination of nitroprusside
(0.2e10 mg/kg/min) and short-acting beta-blockers (esmo-
lol 50e300 mg/kg/min intravenously, if necessary; dose
0.2e0.7 mg/kg/min). An intravenous infusion of dexmede-
tomidine was also added in some patients to achieve he-
modynamic control.
2.3. Postoperative management
Patients with cortisol-secreting adenoma were treated with
intravenous stress doses of hydrocortisone (1e2 mg/kg) or
prednisolone (25 mg) during the three doses a day of the
operation. After first post-operative day, steroid replace-
ment therapy was performed orally, with hydrocortisone or
prednisolone tablets (a dose of 10 mg in the morning and a
dose of 5 mg in the evening). Postoperative hypotensive
crises were treated by hydrocortisone and crystalloids.
During the follow-up period, the referral endocrinologist
strictly followed all patients and an endocrine workup was
performed once a year to exclude recurrence. Diastolic
blood pressure levels < 90 mmHg were considered hypo-
tensive crises.
2.4. Surgical technique
All adrenalectomies were performed through a lateral
transperitoneal laparoscopic approach using three or
four ports. Harmonic scalpel (Ethicon Endo-Surgery, Inc.,
Cincinnati, USA) or LigaSure vessel sealing system (Tyco,
Boulder, Colorado, USA) was routinely used for the dissec-
tion of the adrenal glands. The surgical specimens were
extracted in retrieval bags through a minilaparotomy
approach at the site of one of the trocars.
The operative time was determined as the period from
skin incision to wound dressing. An antibiotic and antith-
rombotic prophylactic therapy was administered in all
cases. All adrenalectomies were performed using a stan-
dard transperitoneal lateral laparoscopic approach (4 tro-
cars were used if the tumor was in the right adrenal gland,
whereas 3 trocars were used if the tumor was in the left
adrenal gland; Figures 1 and 2). The patients were placed in
the left or right lateral decubitus position (on the sideopposite to the tumor; w45 for right LA and w90 for left
LA).
For right adrenalectomy, the insertion of Veress needle
and camera is similar to the procedure mentioned earlier
for left adrenalectomy. A second 10-mm and third 5-mm
trocar were placed on the posterior axillary line and mid-
clavicular line, respectively. The working instruments were
introduced from these regions. In addition, a 10-mm trocar
was placed at the epigastrium for liver retractor insertion
(Figure 1). The liver was retracted using a retractor and the
triangular ligament was dissected to free the liver from the
diaphragm, thereby allowing its medial retraction.
Increased attention is needed in patients with Cushing’s
syndrome, as their liver may be very fragile and could be
easily damaged. While dissecting the right-sided tumors,
the inferior vena cava was identified early in the proce-
dure. The connective tissue between the medial border of
the adrenal gland and the vena cava was carefully
dissected. The right adrenal vein, which is shorter, was
identified early in the dissection, and was clipped and
divided (Figure 3).
For left adrenalectomy, the Veress needle was inserted
3 cm under the costal margin at the anterior axillary line.
Then, pneumoperitoneum was created by insufflation of
carbon dioxide up to 15 mmHg. The 10-mm trocar was
replaced by a 30 10-mm camera. A second 5-mm and third
10-mm trocar were replaced on the posterior axillary line
and midclavicular line, respectively (Figure 2). The working
instruments were introduced from these regions. The
splenophrenic, splenocolic, and splenorenal ligaments are
identified and divided. This allows for medial rotation of
the spleen and tail of pancreas, exposing the renal vein.
The splenic vein can be identified at this point, which runs
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fascia is opened to identify the superior margin of the left
renal vein. This is followed medially until its junction with
the inferior adrenal vein is identified. The adrenal vein is
clipped at the level of the renal vein and divided (Figure 4).
The gland is freed from surrounding tissues and the spec-
imen is usually removed using an Endobag from near the
region where the camera enters.
2.5. Statistical analyses
The results are expressed as mean  standard deviation
and/or median (range). Statistical analyses were performed
using one-way analysis of variance and Chi-square test. A p
value < 0.05 was taken to be significant.
3. Results
A total of 100 laparoscopic resections were performed,
predominantly for functional adrenal tumor (66 cases;
Group 1) and 34 cases received laparoscopic resection for
nonfunctional adrenal tumor (Group 2). Group 1 included 21
cases of PH, 16 cases of Conn’s syndrome, and 28 cases of
Cushing’s syndrome. The demographic data of patients and
the clinical outcome of patients who underwent LA in each
group are presented in Tables 1 and 2, respectively. Be-
tween the groups, there was no statistical difference in
age, BMI, sex, and localization of lesion. Although the size
of the lesion was greater in Group 2, no statistically sig-
nificant difference was observed (p Z 0.19). The median
operative time was 101  4.3 minutes (range 30e210 mi-
nutes) in Group 1 and 95  5.9 minutes (range 30e190
minutes) in Group 2, and this was not statistically signifi-
cant (p Z 0.56). In addition, there was no significant dif-
ference between the groups in terms of blood transfusion
and the type of the resected lesion (p Z 0.5).
Of the total 100 LA procedures carried out, 59 were
performed on the right side and 41 on the left side. Ac-
cording to the tumor localization, the operative time was
99.7  4.6 minutes (range 30e210 minutes) on the right
side and 98.7  45.5 minutes (range 30e190 minutes) on
the left side, which was also not statistically significant
(p Z 0.89).
Perioperative blood transfusions were required in three
patients (4.5%) in Group 1 and 1 (2.9%) patient in Group 2.Figure 3 Clipping of the right adrenal vein.Perioperative complications occurred in nine (5 on the right
side and 4 on the left side, 9%) patients from both Groups 1
and 2. Six (9%) patients in Group 1 suffered intraoperative
bleeding (Grade II complication) and three (8.8%) patients
in Group 2 suffered intraoperative bleeding (nZ 2; Grade II
complication) and diaphragm rupture (n Z 1; Grade III
complication), according to the Clavien classification.10
However, these were not statistically significant
(p Z 0.96). The common perioperative complication was
intraoperative bleeding (n Z 8/9). The perioperative
complication rate on the right side was 10.3%, and the
corresponding rate on the left side was 7.3%, which was
also not statistically significant (p Z 0.62).
In the postoperative period, three patients in Group 1
and one patient in Group 2 developed complications;
however, this difference was also not statistically signifi-
cant (p Z 0.69). These complications were adrenal insuf-
ficiency in one patient and atelectasis in two patients in
Group 1, whereas the one patient in Group 2 suffered
incisional hernia. The median duration of the postoperative
hospital stay in Group 1 was longer than that in Group 2, but
again this did not differ significantly (p Z 0.08). The ratio
of conversion to open surgery in this study was 8%. Five
patients in Group 1 and three patients in Group 2 converted
to open surgery, which was also not statistically significant
(p Z 0.82). The reasons for conversion to open surgery in
the two groups are provided in Table 3. One of reasons for
conversion was bleeding (5 patients) and the diagnosis of
these patients is as follows: PH (n Z 2), nonfunctioning
adenoma (nZ 2), and Conn’s syndrome (nZ 1). The other
reason for conversion was difficulty in dissecting, which was
the case in three patients whose diagnosis are as follows:
Cushing’s syndrome (2 patients) and nonfunctional tumor (1
patient). Diaphragm rupture occurred in one patient. The
patient with diaphragm perforation was treated with tube
thoracostomy. Nine patients had conversion to open surgery
(9%). The conversion was 6.8% on the right side and 9.7% on
the left side, which was not statistically significant
(p Z 0.59).
The demographic data and clinical outcome of the
functional tumors (Group 1) including Cushing’s syndrome,
Conn’s syndrome, and PH are presented in Table 4. Cush-
ing’s syndrome was the leading indication for adrenalec-
tomies in all cases (28/66). The median size of the lesion
excised was 2.8  0.1 cm (range 2.1e5 cm). The median
BMI in those with Cushing’s syndrome was 27.4  0.5 kg/m2,Figure 4 Clipping of the left adrenal vein.
Table 3 Reasons for conversion to open surgery in the
patients with laparoscopic adrenalectomy.
Group 1 Group 2
Bleeding 3 2
Difficulty in dissecting 2 1
Table 1 Demographic data of patients who underwent laparoscopic adrenalectomy and tumor characteristics.
Group 1 Group 2 p
Sex (male/female) 25/41 13/21 0.96
BMI, kg/m2 26  0.32 5.8  0.5 0.92
Median age (y) 51.4  0.7 (35e65) 52.3  12.1 (40e67) 0.46
Tumor localization (right/left) 37/29 23/11 0.25
Median tumor size (cm) 3.8  0.1 (1.5e8) 4.1  0.2 (3.5e7) 0.19
Data are presented as mean  SD (range), unless otherwise indicated.
BMI Z body mass index; SD Z standard deviation.
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(p Z 0.02 and p Z 0.001, respectively). The median
diameter of the tumor in patients with PH was 5.8  0.1 cm
(range 4.5e8 cm), which was larger than those with Cush-
ing’s syndrome and Conn’s syndrome (p < 0.0001 and
p < 0.0001, respectively). The median diameter of the
tumor in patients with Cushing’s syndrome and Conn’s
syndrome was 2.8  0.1 cm (range 2.1e5 cm) and
2.3  0.1 cm (range 1.5e3.5 cm), respectively, which was
statistically significant (p Z 0.004). The median operative
time in patients with PH was longer than those with Cush-
ing’s syndrome and Conn’s syndrome, which was statisti-
cally significant (p Z 0.013 and p Z 0.004, respectively).
The median operative time in Cushing’s syndrome and Conn
syndrome was 94.3  6.3 min (range, 40e160 min) and 88 
8.3 min (range, 30e120 min), respectively, but this did not
differ significantly (p Z 0.49). With regard to functional
tumors, the results were similar in terms of age, tumor
location, duration of hospital stay, rate of conversion,
blood transfusion, postoperative complication, and con-
version from laparoscopic to open surgery (p > 0.05).
In the histopathological examination, benign adenoma,
cortical hyperplasia, myelolipomas, and other masses were
seen in 85 patients (85%), eight patients (8%), two patients
(2%), and five patients (5%), respectively.
All patients with PH were admitted at least 14 days prior
to the operation for pharmacological blockade, which
administered under the care of the endocrinology service
team. Two patients required nitroprusside intraoperatively
for blood pressure control and one required transfer to the
intensive care unit for close blood pressure monitoring, but
was discharged quickly with no sequelae. There was no
mortality.4. Discussion
Our results show that laparoscopic lateral transabdominal
adrenalectomy is a safe, effective, and technically feasibleTable 2 Clinical outcome of patients who underwent laparosco
Group 1
Median operation time (min) 101  4.3 (30e210
Conversion to open surgery 5/66 (9.1)
Hospital stay (d) 3.4  0.1 (2e10)
Perioperative complication 6/66 (9%)
Data are presented as n/N (%) or mean  SD.procedure in the treatment of both functioning and
nonfunctioning benign tumors of the adrenal gland. Intro-
duction of LA has led to a radical change in the surgical
approaches to tumors in the adrenal gland. LA has become
the preferred surgical procedure for the treatment of both
functional and nonfunctional adrenal tumors.1,2 As re-
ported by many studies, the major advantages can be
summarized as follows: (1) the adrenal glands can
anatomically be demonstrated more effectively using lap-
aroscopy; (2) the adrenal tissue, which is a fragile organ,
can easily be dissected; (3) despite its rich vascular struc-
ture, effective homeostasis has been achieved in recent
years.11e14 In several previous studies, it has been shown
that this minimally invasive technique is superior to con-
ventional methods in safety, efficacy, and
complication.11e13,15e17 Different laparoscopic approaches
have been tried in recent times. The lateral transperitoneal
approach offers several benefits for the surgeon including
the following: (1) more clear exhibition of important
anatomical structures; (2) the spleen and liver can be
retracted easily; and (3) if necessary, it allows the transi-
tion to hand-assisted technique. By contrast, the advan-
tages of the retroperitoneal approach are limited injuries
to visceral organs and lesser postoperative intestinal com-
plications, particularly the ileus.18 Cushing’s syndrome,
Conn’s syndrome, PH, and incidentalomas, although of
different adrenal origins and variable clinical symptoms,
can be treated successfully with laparoscopic ap-
proaches.8,11,18 The results of these procedures are not
generally considered to be associated with secretion of
hormones by the adrenal lesions.8,9,19 Our study resultspic adrenalectomy.
Group 2 p
) 95  5.9 (30e190) 0.36
3/34 (5.9) 0.82
2.9  0.2 (2e7) 0.08
3 (8.8%) 0.96
Table 4 Demographic data and clinical outcome of the functional tumors.
Patients PH Cushing’s syndrome Conn’s syndrome
Age (y) 50  1.3 (39e65) 51  1.2 (35e60) 52  1.6 (40e67)
BMI (kg/m2) 24.5  0.5 27.4  0.5 25.1  0.6
Localization (right & left) 13 & 8 14 & 14 9 & 7
Diameter (cm) 5.8  0.1 (4.5e8) 2.8  0.1 (2.1e5) 2.3  0.1 (1.5e3.5)
Operative time (min) 121  7.1 (65e210) 94.3  6.3 (40e160) 88  8.3 (30e120)
Hospital stay (d) 3.5  0.2 (3e7) 3.5  0.2 (3e10) 3.0  0.2 (2e6)
Blood transfusion 1 1 1
Conversion to open surgery 2 2 1
Perioperative complication 2 2 2
Data are presented as N or mean  SD (range).
BMI Z body mass index; PH Z pheochromocytoma.
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studies. There was no difference between the groups in
postoperative results, including duration of hospital stay,
rate of conversion, blood transfusion, postoperative
complication, and conversion to open surgery.
Although the lesion size in PH cases is significantly
larger, there is no significant difference in operative time
and postoperative process compared with other functional
adrenal tumors in this study. PHs have a risk of hypotensive
or hypertensive crisis during the surgery, owing to excessive
catecholamine release, which cannot be completely
impeded even by following adequate preoperative pro-
cedures, which involve administration of a and b
blockers.20 In this study, a and b blockers were adminis-
tered to patients 10e14 days prior to the operation. Despite
all these measures, postoperative hypotensive and intra-
operative hypertensive crises occurred one patient and two
patients, respectively.
When the lesion size is > 4 cm, surgery is recommended.
However, when lesions are < 4 cm but are associated with
severe hypertension, surgery is indicated.21 Adrenal tumors
> 13 cm and found to be locally advanced (i.e., invasion of
adjacent organ or structure) are considered to be contra-
indications for the laparoscopic approach.22 Gumbs and
Gagner23 have shown that the mean size of the lesion was
largest in patients with PH and suggested that hormonal
disorder had no effect on operative time; however, they
noted that blood loss was higher in patients with PH. Be-
sides, another study showed that diagnosis of PH is associ-
ated with increased blood loss.24 This condition may be
associated with significant tumor vascularity and larger size
of the tumor. In this study, the operative time for patients
with PH is longer than those with other functional tumors.
However, postoperative results are similar among patients
with functional tumors. Several studies have reported a
mean hospital stay of 2.5e5 days, which is parallel to the
results in this study.6,13,15e17
The mean operative times for functional tumors (Group
1) and nonfunctional tumors (Group 2) were 101  4.3 mi-
nutes (range 30e210 minutes) and 95  5.9 minutes (range
30e190 minutes), respectively (p Z 0.56), which are
comparable to those reported by Chuan-Yu et al25 (95  29
minutes) and Kulis et al26 (102 minutes). However,
compared with the operative time in this study, several
studies have reported higher ranges.12,13,15,27,28 Weattribute this difference to the following reasons: (1)
tumors > 8 cm and cases suspected to be malignant were
excluded from this study; (2) all procedures were per-
formed only by an experienced endocrine surgeon; (3)
advanced devices such as LigaSure and Harmonic scalpel
were used for dissection during LA.
Contraindications to LA in the literature are malignant
tumors, tumors > 12 cm, evidence of invasion, and patient
fitness. Furthermore, tumors with diameter > 6e8 cm carry
a risk of malignancy.12 LA is considered the gold standard
only for tumors < 8 cm.27 Therefore, we performed LA only
in tumors measuring up to 8 cm. Our indications for con-
version to an open approach were similar to those reported
previously. These include dense adhesions and bleeding
uncontrolled by laparoscopic techniques with impaired
visualization.29 In similar studies, the rates of conversion to
open surgery have been reported to be 0e23%, which are
parallel to those reported in this study.18,21,25,26
Intraoperative hemorrhage is the most common
complication reported in open and LA, as seen in our
study.30 Upon comparing the intraoperative (conversion to
open) and postoperative complications between the two
groups, both the tumor types and presence or absence of
their functions were found not to have any significant ef-
fect. Some authors observed that the intraoperative
complication rates were higher in patients who received
surgery for PH.14,25,26 However, according to some authors,
the number of complications associated with laparoscopic
removal of PH primarily depends on the experience of the
surgeon in performing laparoscopic approaches.23 In our
study, when the cases in Group 1 were compared with each
other, the lesion size in patients who were operated for PH
was significantly larger than that in other patients, but this
difference did not produce any significant difference in
postoperative development. Thus, it can concluded that
the complications developed in these patients may be
related to the experience of the surgeon in performing LA
(and hence these patients required conversion to open
surgery), rather than to hormonal disorders. Shen et al31
analyzed 456 cases of LA, and suggested that the diag-
nosis of PH, tumor size, and BMI are all predictive factors
for conversion to open procedure. In our study, although
higher BMI in patients with Cushing’s syndrome and marked
increase in tumor size in patients with PH were found,
there was no significant difference between the two
Functional and nonfunctional adrenal tumors 143groups and functional tumor regarding conversion to open
surgery.
We also evaluated the effect of the tumor localization
on operative results including operative time, preoperative
complications, conversion to open surgery; however, our
analysis showed that there was no difference between each
side (left vs. right) with regard to operative results, which is
parallel to the result reported in literature.32 Rieder et al33
found no difference in complication or conversion rate with
regard to the sides LA was performed, but the authors
indicated lower operative time for the right-side LA. Gau-
joux et al34 found that left-sided LA is associated with
increased postoperative complications.
A limitation of this study is the inherent selection bias in
the retrospective review. The advantage of this study is the
similarity of the patient’s demographic data, which
enabled us to compare the two groups more accurately.
In conclusion, this study shows that independent of
different hormonal activities, LA is a safe approach for the
adrenal benign lesions. The results of the procedure do not
generally depend on the type of hormonal disorder diag-
nosed with adrenal tumor.
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